Cargando…

Dysregulation of follicle development in a mouse model of premature ovarian insufficiency

Premature ovarian insufficiency (POI) occurs in 1% of reproductive-age women. The ovarian manifestation ranges from the presence of a variable population of follicles (follicular) to the absence of follicles (afollicular), and in the majority of cases the cause is unknown. A transgenic mouse model o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Grasa, P, Sheikh, S, Krzys, N, Millar, K, Janjua, S, Nawaggi, P, Williams, S A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bioscientifica Ltd 2016
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5111581/ https://www.ncbi.nlm.nih.gov/pubmed/27581083 http://dx.doi.org/10.1530/REP-16-0091

Ejemplares similares

CPEB3 deficiency in mice affect ovarian follicle development and causes premature ovarian insufficiency
por: E., Fang, et al.
Publicado: (2021)

Dysregulated cytokine profile associated with biochemical premature ovarian insufficiency
por: Liu, Peihao, et al.
Publicado: (2020)

The potential of follicle-stimulating hormone peptide-modified triptolide-loaded nanoparticles to induce a mouse model of premature ovarian insufficiency
por: Chen, Xiu-Ying, et al.
Publicado: (2015)

Dysregulation of follicle fatty acid is a potential driver of human primary ovarian insufficiency
por: Wang, Lina, et al.
Publicado: (2020)

Rapid ovarian transcript changes during the onset of premature ovarian insufficiency in a mouse model
por: Kaune, Heidy, et al.
Publicado: (2022)

COMT polymorphism influences decrease of ovarian follicles and emerges as a predictive factor for premature ovarian insufficiency
por: Cordts, Emerson Barchi, et al.
Publicado: (2014)

The Role of Gene Therapy in Premature Ovarian Insufficiency Management
por: Atabiekov, Ihor, et al.
Publicado: (2018)

Metabolic dysregulation in patients with premature ovarian insufficiency revealed by integrated transcriptomic, methylomic and metabolomic analyses
por: Lu, Cuiling, et al.
Publicado: (2022)

The Role of Lifestyle and Dietary Factors in the Development of Premature Ovarian Insufficiency
por: Shelling, Andrew N., et al.
Publicado: (2023)

Premature ovarian insufficiency: Pathogenesis and management
por: Fenton, Anna J.
Publicado: (2015)

POI: Premature Ovarian Insufficiency/Pregnancy or Infertility?
por: Soave, Ilaria, et al.
Publicado: (2013)

Mood disorders in women with premature ovarian insufficiency
por: Słopień, Radosław
Publicado: (2018)

Metabolic Profile of Patients with Premature Ovarian Insufficiency
por: Podfigurna, Agnieszka, et al.
Publicado: (2018)

Role of microRNAs in premature ovarian insufficiency
por: Guo, Ying, et al.
Publicado: (2017)

Meiotic Recombination Defects and Premature Ovarian Insufficiency
por: Huang, Chengzi, et al.
Publicado: (2021)

Premature Ovarian Insufficiency: Past, Present, and Future
por: Chon, Seung Joo, et al.
Publicado: (2021)

Diagnostic challenges in suspected premature ovarian insufficiency
por: Armeni, Eleni
Publicado: (2022)

Plasma metabolomic characterization of premature ovarian insufficiency
por: Zhou, Xing-Yu, et al.
Publicado: (2023)

Landscape of pathogenic mutations in premature ovarian insufficiency
por: Ke, Hanni, et al.
Publicado: (2023)

Primordial follicle activation as new treatment for primary ovarian insufficiency
por: Lee, Hye Nam, et al.
Publicado: (2019)

Biological therapies for premature ovarian insufficiency: what is the evidence?
por: Moustaki, Melpomeni, et al.
Publicado: (2023)

Safety of Intraovarian Injection of Human Mesenchymal Stem Cells in a Premature Ovarian Insufficiency Mouse Model
por: Park, Hang-Soo, et al.
Publicado: (2021)

Diosmin Mitigates Cyclophosphamide Induced Premature Ovarian Insufficiency in Rat Model
por: Abogresha, Noha M., et al.
Publicado: (2021)

Possible Role of Autoimmunity in Patients with Premature Ovarian Insufficiency
por: Košir Pogačnik, Renata, et al.
Publicado: (2014)

Premature ovarian insufficiency: the context of long-term effects
por: Podfigurna-Stopa, A., et al.
Publicado: (2016)

Premature ovarian insufficiency – aetiopathology, epidemiology, and diagnostic evaluation
por: Rudnicka, Ewa, et al.
Publicado: (2018)

Consequences of premature ovarian insufficiency on women’s sexual health
por: Maciejewska-Jeske, Marzena, et al.
Publicado: (2018)

Premature Ovarian Insufficiency: Procreative Management and Preventive Strategies
por: Chae-Kim, Jennifer J., et al.
Publicado: (2018)

Rare variants in FANCA induce premature ovarian insufficiency
por: Yang, Xi, et al.
Publicado: (2019)

Therapeutic options for premature ovarian insufficiency: an updated review
por: Huang, Qiao-yi, et al.
Publicado: (2022)

Characteristics of the vaginal microbiome in women with premature ovarian insufficiency
por: Wu, Jiaman, et al.
Publicado: (2021)

Association between premature ovarian insufficiency and gut microbiota
por: Wu, Jiaman, et al.
Publicado: (2021)

Association of Coenzyme Q10 with Premature Ovarian Insufficiency
por: Ma, Linjuan, et al.
Publicado: (2022)

Parsing Genetic and Autoimmune Etiology in Premature Ovarian Insufficiency
por: Nauwynck, Elise, et al.
Publicado: (2023)

Transient Premature Ovarian Insufficiency Post-COVID-19 Infection
por: Gorman, Colleen N, et al.
Publicado: (2023)

New Hopes for the Treatment of Primary Ovarian Insufficiency/Premature Ovarian Failure
por: Sadeghi, Mohammad Reza
Publicado: (2013)

In vitro and in vivo mouse follicle development in ovaries and reaggregated ovaries
por: Lo, Belinda K M, et al.
Publicado: (2018)

Follicular development during hormone replacement therapy in patients with premature ovarian insufficiency
por: Sato, Takuma, et al.
Publicado: (2021)

BCAA insufficiency leads to premature ovarian insufficiency via ceramide‐induced elevation of ROS
por: Guo, Xiao, et al.
Publicado: (2023)

Incidence and familial risk of premature ovarian insufficiency in the Finnish female population
por: Silvén, H, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_o99k584g3hifpur05k0bvlk2r8